Linked Life Data

17962052

Source:http://linkedlifedata.com/resource/pubmed/id/17962052

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2007-11-27
pubmed:abstractText
The development of a cell therapy for the neurodegenerative disorder Parkinson's disease is a realistic ambition. It is pursued by researchers and companies alike, and spans different donor tissue types of embryonic, fetal and adult origins. In this review, we briefly outline the past and current status of research and clinical trials with cell transplantation in Parkinson's disease. We discuss studies on donor tissue derived from embryonic ventral mesencephalon and assess the current research on various forms of stem cells of both embryonic and adult origins in the quest to develop a cell-based therapy for this debilitating movement disorder.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1084-9521
pubmed:author
pubmed:issnType
Print
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
859-69
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Restorative cell therapy for Parkinson's disease: a quest for the perfect cell.
pubmed:affiliation
Neuronal Survival Unit, Department of Experimental Medical Science, Wallenberg Neuroscience Center, Solvegatan 17, BMC A10, Lund 22184, Sweden. Vanessa.hall@med.lu.se
pubmed:publicationType
Journal Article, Review